课题基金 / 基金详情

Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy

Role of Alpha 2 Collagen VIII in Fuchs Corneal Dystrophy
Alpha 2 VIII 胶原蛋白在福克斯角膜营养不良中的作用
批准号:
6765443
负责人:
ALBERT S JUN
金额:
$21.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2009-06-30

项目摘要

项目成果

ALBERT S JUN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to provide the principal investigator (PI) with the experiences and skills necessary to become an independent researcher studying basic mechanisms of corneal diseases. The scientific focus of this proposal is to gain a better understanding of the cellular and extracellular matrix (ECM) protein abnormalities caused by mutations in collagen VIII which lead to corneal endothelial cell (CEC) loss in Fuchs endothelial dystrophy (FED). Collagen VIII (COL8) plays a central role in the formation of Descemet membrane (DM), the specialized basement membrane of CECs, and mutations in the gene encoding the alpha2 chain of collagen VIII (COLSA2) cause FED in some patients. FED progresses over decades in humans and accounts for up to 29% of corneal transplants. Early stages of the disease are asymptomatic, and mildly affected tissues are not available. Thus, virtually no information exists about the early cellular and ECM changes leading to FED. Understanding these early pathogenic events could be increased greatly through the development of a reliable animal model of FED as well as detailed biochemical analysis of pathogenic COL8A2 mutations on collagen VIII function. The underlying hypothesis of this proposal is that mutations in the COL8A2 gene produce cellular and biochemical abnormalities which cause CEC loss in FED. Identifying these abnormalities should provide important insights into the pathogenesis of FED, which may suggest rational therapies for this important corneal disease. To address this hypothesis, two specific aims are proposed: Aim 1: To develop and characterize a mouse model of FED by introducing the R155Q COL8A2 mutation using gene targeting techniques. Aim 2: To investigate the effects of COLSA2 mutations known to cause FED on homotrimer and heterotrimer formation with alpha1 collagen VIII, the other COL8 subchain interacting with COL8A2 in vivo. In the course of the proposed research and selected didactic activities, the PI will gain invaluable training experience and mentoring in developing animal models of ocular disease and biochemical analyis of ECM proteins. Expertise in these areas is deemed invaluable for the PI who aspires to develop an independent research program studying basic mechanisms of corneal diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis and CRISPR/Cas9 Correction of TCF4 Expansion in Fuchs Dystrophy
  • 批准号:
    9018954
  • 项目类别:
  • 资助金额:
    $24.3万
  • 财政年份:
    2015
  • 负责人:
    ALBERT S JUN
  • 依托单位:
Pathogenesis and CRISPR/Cas9 Correction of TCF4 Expansion in Fuchs Dystrophy
  • 批准号:
    9181443
  • 项目类别:
  • 资助金额:
    $20.25万
  • 财政年份:
    2015
  • 负责人:
    ALBERT S JUN
  • 依托单位:
Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
  • 批准号:
    8123246
  • 项目类别:
  • 资助金额:
    $39.36万
  • 财政年份:
    2010
  • 负责人:
    ALBERT S JUN
  • 依托单位:
Role of unfolded protein response and COL8A2 in Fuchs corneal dystrophy
  • 批准号:
    7987111
  • 项目类别:
  • 资助金额:
    $41.0万
  • 财政年份:
    2010
  • 负责人:
    ALBERT S JUN
  • 依托单位:
海外基金